- US markets turned lower on Thursday with the Dow losing 1.02%, S&P500 declining 1.16% and Nasdaq suffering another steep decline, this time of 1.47%
- This remains in start contrast with the European and the Chinese equity markets that remain buoyant this year – yesterday both the DE30 and CHNComp saw just a minor hesitation and today DE30 is already recovering, while CHNComp is modestly down
- The news flow remains supportive in Europe on the inflation front, after better data from Germany and France, yesterday we had lower inflation in Italy (11.6%) and lower PPI inflation in the EMU (27.1% vs 27.7% expected, data for November), mostly on lower energy prices
- Meanwhile in the US the data remains troublesome: while the activity is slowing down (PMI services down to 44.7 points and lower trade numbers), labour market remains strong with ADP at +235k (150 expected) and claims at 204k (230k expected)
- The message from the Fed remains far from soothing as well – James Bullard said yesterday that rates were still not as restrictive as necessary and any discussion on inflation target change would be “very wrong”
- Tesla slashed prices in China for the second time in 3 months in a move that may raise concerns about the demand for its vehicles – stock prices remain close to the lowest point since mid-2020
- AUD is the strongest while JPY is the weakest on the NFP day (1:30 GMT) as some smaller markets are closed due to the Epiphany
DE30 ignores Wall Street weakness and climbs towards the resistance zone that was rejected late in 2022
Daily Summary: A shift in sentiment at the end of the day 💥⬇️
US OPEN: Wall Street opens higher 🔼 Datadog and ARM in the spotlight 💥
Market wrap 🚨Oil slips below $100 supporting optimism across European and US stocks
Chart of the Day: EURUSD Higher, but Still a Game of Expectations, Not a Trend
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
